Pages that link to "Item:Q10740"
Jump to navigation
Jump to search
The following pages link to Section 7: Treatments for SARS-CoV-2 Infection (from DOI: 10.1007/s11886-020-01292-3) (Q10740):
View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)- Section 1: Introduction (from DOI: 10.1007/s11886-020-01292-3) (Q10734) (← links)
- Section 2: Biology of SARS-CoV-2 (from DOI: 10.1007/s11886-020-01292-3) (Q10735) (← links)
- Section 3: The Role of Host Immune Response (from DOI: 10.1007/s11886-020-01292-3) (Q10736) (← links)
- Section 4: Viral Toxicity and Myocardial Injury in COVID-2 (from DOI: 10.1007/s11886-020-01292-3) (Q10737) (← links)
- Section 5: Immune Responses to SARS-CoV-2 Infection and the Heart (from DOI: 10.1007/s11886-020-01292-3) (Q10738) (← links)
- Section 6: Host-Specific Variations in COVID-19 Immune Response (from DOI: 10.1007/s11886-020-01292-3) (Q10739) (← links)
- Section 7: Treatments for SARS-CoV-2 Infection (from DOI: 10.1007/s11886-020-01292-3) (Q10740) (← links)
- Section 8: Conclusion (from DOI: 10.1007/s11886-020-01292-3) (Q10741) (← links)
- Conflict of Interest (from DOI: 10.1007/s11886-020-01292-3) (Q10742) (← links)
- References (from DOI: 10.1007/s11886-020-01292-3) (Q10743) (← links)
- Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response (DOI: 10.1007/s11886-020-01292-3) (Q11196) (← links)